Wang Z, Zhao J, Ma Z, Cui J, et al. Corrigendum to "A phase 2 study of tislelizumab in combination with platinum-based chemotherapy as first-line treatment for advanced lung cancer in Chinese patients" [Lung Cancer 147 (2020) 259-268]. Lung Cancer 2021 Jun 11. pii: S0169-5002(21)00426.
PMID: 34127281